My watch list
my.bionity.com  
Login  

Topic business development

Companies business development

Tytonis BV, Germany

Tytonis -as integral part of a reputated, worldwide network of high-class, independent experts- offers services in all relevant areas of the pharmaceutical value chain. Focus areas are license transactions (deal values negotiated > 100 million Euros), valuations (corporate and products), portfoliost more

Life Science Consult, Germany

For more than 10 years have we been offering systematic searches for product and business development partners, also for specialists and executives to assist in growing your business. In excess of 3.000 contacts in our database are known in person, all can be accessed for advice. Potential partner more

News business development

  • Algeta appoints Dr. Donald Coppen as Business Development Director

    Algeta ASA announced that it has appointed Donald Coppen as Business Development Director.Dr. Coppen will join Chief Business Officer Roger Harrison in driving Algeta's business development strategy aimed at advancing its Thorium payload technology for creating novel targeted cancer therapies, and e more

  • Michael Krel joins Deinove as Business Development Director

    Deinove announced the appointment of Michael Krel to the newly created post of Executive Vice President, Business Development. For the three years prior to joining Deinove, Michael Krel served as Business Development Manager at Metabolic Explorer, a green chemistry company specializing in the develo more

  • OGT Grants DNA Sequence Variation Licence to Biotype Diagnostics GmbH

    Oxford Gene Technology (OGT) and Biotype Diagnostics GmbH announced the completion of a licence agreement granting Biotype access to OGT patents for the detection of DNA sequence variations. The licence, which will remain valid for the lifetime of the patents, provides Biotype with certain rights wi more

All news on business development

White papers business development

Publications business development

  • Deal watch: Is deal-making becoming more difficult?

    Deal watch: Is deal-making becoming more difficult? Nature Reviews Drug Discovery 10, 404 (2011). doi:10.1038/nrd3464 Author: Nigel Borshell There has been much speculation on the impact of economic volatility and financial stress on deal-making over the past few years. To i more

Market studies business development

  • 2012 Deep Research Report on Global and China Hemodialysis Machine Industry

    2012 Deep Research Report on Global and China Hemodialysis Machine Industry was published by QYResearch Medical Equipment Research Center on Jan 2012. It was a professional and depth research report on Global and China Hemodialysis Machine Industry. Firstly the report describes the background knowle more

  • 2012 Deep Research Report on China Influenza Vaccine Industry

    2012 Deep Research Report on China Influenza Vaccine Industry was a professional and depth research report on China Influenza Vaccine Industry. Firstly the report describes the background knowledge of Influenza Vaccine, including Concepts Classification Manufacturing process technical parameters and more

  • Hybrigenics S.A. (ALHYG) - Financial and Strategic SWOT Analysis Review

    Hybrigenics S.A. (ALHYG) - Financial and Strategic SWOT Analysis Review Summary Hybrigenics S.A. (Hybrigenics) is a France-based bio-pharmaceutical company engaged in discovery and development of therapies for the treatment of cancer and commercialization of its technology and bioinformatics platf more

All market studies on business development

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE